PICK A TIME SLOT
₹ Price not available
Mangalore
Book an appointment for Consultation
₹ Price not available
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
-
-
-
-
-
-
Publications
Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route.
His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.
He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University).
An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).
Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.
During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant.
- Coronary Interventions
- FSCAI
- FESC
- Kannada
- Hindi
- English
- Tulu
- Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
- Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
- Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
- Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
- Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
- Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
- Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
- Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
- Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
- Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
- Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
- Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
- Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
- An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
- Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
- Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
- Dr. Rajesh Bhat U in an authored article says | Festive celebrations? Keep heart healthy and don't overindulge | Times of IndiaClick Here
Overview
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
- FSCAI
- FESC
Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route.
His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.
He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University).
An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).
Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.
During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant.
- Coronary Interventions
- Kannada
- Hindi
- English
- Tulu
- Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
- Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
- Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
- Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
- Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
- Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
- Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
- Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
- Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
- Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
- Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
- Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
- Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
- An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
- Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
- Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
- Dr. Rajesh Bhat U in an authored article says | Festive celebrations? Keep heart healthy and don't overindulge | Times of IndiaClick Here
Fellowship & Membership
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
- Kannada
- Hindi
- English
- Tulu
Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route.
His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.
He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University).
An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).
Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.
During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant.
- FSCAI
- FESC
- Coronary Interventions
- Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
- Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
- Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
- Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
- Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
- Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
- Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
- Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
- Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
- Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
- Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
- Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
- Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
- An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
- Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
- Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
- Dr. Rajesh Bhat U in an authored article says | Festive celebrations? Keep heart healthy and don't overindulge | Times of IndiaClick Here
Languages Spoken
Overview
Fellowship & Membership
Field of Expertise
Awards & Achievements
Talks & Publications
- Coronary Interventions
- FSCAI
- FESC
- Kannada
- Hindi
- English
- Tulu
- Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
- Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
- Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
- Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
- Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
- Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
- Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
- Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
- Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
- Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
- Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
- Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
- Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
- An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
- Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
- Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
- Dr. Rajesh Bhat U in an authored article says | Festive celebrations? Keep heart healthy and don't overindulge | Times of IndiaClick Here
Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route.
His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.
He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University).
An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).
Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.
During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant.
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
Overview
- Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
- Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
- Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
- Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
- FSCAI
- FESC
- Coronary Interventions
- Kannada
- Hindi
- English
- Tulu
- Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
- Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
- Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
- Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
- Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
- Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
- Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
- Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
- Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
- An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
- Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
- Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
- Dr. Rajesh Bhat U in an authored article says | Festive celebrations? Keep heart healthy and don't overindulge | Times of IndiaClick Here
Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route.
His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.
He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University).
An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).
Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.
During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant.
Awards & Achievements
Fellowship & Membership
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
- Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
- Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
- Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
- Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
- Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
- Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
- Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
- Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
- An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
- Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
- Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
- Dr. Rajesh Bhat U in an authored article says | Festive celebrations? Keep heart healthy and don't overindulge | Times of IndiaClick Here
Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route.
His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.
He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University).
An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).
Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.
During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant.
- FSCAI
- FESC
- Coronary Interventions
- Kannada
- Hindi
- English
- Tulu
- Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
- Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
- Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
- Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
Talks & Publications
Overview
Fellowship & Membership
Field of Expertise
Languages Spoken
Awards & Achievements
Blogs
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
